RE:New Year...and buy ratingSo one of the lesser known analysts gives us a speculative buy rating and provides ZERO guidance or reason as to why he advises this price target? Agreed, its a good start, but means nothing untill the company can sell something. I mean correct me if I'm wrong but we're still pre-revenue? A little late to the game. Its funny, its one of my few holdings that actually has insider buying, but im growing more and more impatient with management not hitting targets or actually getting anything to market. We're already in over-supply, so flower just wont cut it unless they can prove a stupid low CPG and undercut everyone else. Like what we have going for the CBD products, and think we can do well with our edibles, but ffs the company needs to GET ON IT! 3rd mover at this point, when it was one of the few companies ahead of the cannabis fenzie two years ago. I fully expect a 1 for 10 rollback, and have priced that into my buying, but this delay is killing us. Nice that they financed, but like everyone else in the sector is all debt, and as most other companies have shown, its not as easy to make money as expected. Gotta right the ship. In a sector where layoffs are happening at an alarming rate, a big facility is almost a burden at this point.